Caxton Associates LLP Takes Position in Encompass Health Corporation $EHC

Caxton Associates LLP purchased a new position in shares of Encompass Health Corporation (NYSE:EHC) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 21,519 shares of the company’s stock, valued at approximately $2,082,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. WPG Advisers LLC boosted its stake in Encompass Health by 73.3% in the fourth quarter. WPG Advisers LLC now owns 324 shares of the company’s stock valued at $34,000 after acquiring an additional 137 shares in the last quarter. Flagship Harbor Advisors LLC purchased a new stake in shares of Encompass Health in the 4th quarter valued at about $37,000. Caitong International Asset Management Co. Ltd boosted its position in shares of Encompass Health by 36,200.0% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock valued at $46,000 after purchasing an additional 362 shares during the period. Assetmark Inc. boosted its position in shares of Encompass Health by 89.6% in the 1st quarter. Assetmark Inc. now owns 455 shares of the company’s stock valued at $44,000 after purchasing an additional 215 shares during the period. Finally, Aster Capital Management DIFC Ltd purchased a new position in Encompass Health during the 4th quarter worth approximately $55,000. 97.25% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

EHC has been the subject of a number of research reports. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Barclays lowered their target price on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 5th. TD Cowen started coverage on shares of Encompass Health in a research report on Thursday, May 28th. They issued a “buy” rating and a $125.00 price target for the company. Leerink Partners set a $152.00 price target on shares of Encompass Health in a research note on Friday, May 22nd. Finally, Weiss Ratings downgraded shares of Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, June 26th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $143.86.

Encompass Health Trading Up 1.4%

NYSE:EHC opened at $112.66 on Friday. Encompass Health Corporation has a 1 year low of $92.77 and a 1 year high of $127.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. The stock has a fifty day moving average price of $104.97 and a two-hundred day moving average price of $103.80. The stock has a market capitalization of $11.18 billion, a price-to-earnings ratio of 18.81, a PEG ratio of 2.42 and a beta of 0.74.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.51 by $0.09. The business had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.57 billion. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. The business’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.37 EPS. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. As a group, sell-side analysts anticipate that Encompass Health Corporation will post 5.96 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be given a dividend of $0.21 per share. The ex-dividend date is Thursday, October 1st. This is an increase from Encompass Health’s previous quarterly dividend of $0.19. This represents a $0.84 annualized dividend and a yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is currently 14.02%.

Insider Transactions at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $104.56, for a total value of $71,309.92. Following the completion of the transaction, the executive vice president directly owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. This trade represents a 2.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.80% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.